Feasibility of olanzapine, multi acting receptor targeted antipsychotic agent, for the prevention of emesis caused by continuous cisplatin- or ifosfamide-based chemotherapy.
Invest New Drugs
; 36(1): 151-155, 2018 02.
Article
em En
| MEDLINE
| ID: mdl-28733700
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antipsicóticos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Cisplatino
/
Olanzapina
/
Ifosfamida
/
Antieméticos
/
Antineoplásicos
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2018